Breast Cancer

New approach seeks to lessen resistance to cancer drugs while mitigating adverse events.

Black men more likely to be diagnosed with breast cancer at a younger age than white men.

Excess medical expenses, employment disability, and a drop in production at work common in cancer survivors.

Study warns that drug reviewers don't look at long term survival of patients.

Particles protected antigen from premature destruction and prompted the immune system to attack cancer cells.

Kjel Jonhson, PharmD, Vice President of Global Oncology for IMS Health, discusses changes in store for the care of cancer patients over the next decade.

Mass spectrometry reveals all proteins that repair damaged cancer DNA.

Genetically determined telomere length may not influence mortality.

Highest uninsured rates found in patients with testicular, stomach, and cervical cancers.

Taking over-the-counter supplements beyond the recommended amount could increase cancer risk.

Suppression of Wnt signaling pathway shows promise.

Re-engineering antibodies allows them to selectively kill tumors.

Regulating PD-L1 protein that helps cancer evade immune system suggests new therapeutic approach.

Researchers determine mechanism for poor survival rates in African American patients with estrogen-receptor positive breast cancer.

Mild cognitive impairment can set in prior to the start of therapy.

Mortality gap in cancer deaths among African Americans and Caucasians may eventually disappear.

Inhibiting a previously undruggable protein holds promise for treatment of numerous types of cancer.

Longer telomeres gives cancer cells a survival advantage.

Analysis of cancer-causing mutations in the BRCA1 or BRCA2 genes may lead to more effective treatments.

Private insurers and Medicare patients can pay up to 43 times less than the uninsured.

Natural extract found to reduce cell growth in triple negative breast cancer.

Less toxic drug class combined with fasting may kill breast, lung, and colon cancer cells equally well.

Compounds that prevent protein aggregation may lead to therapy for conditions such as cancer and diabetes.

Scalp cooling technology seeks to ensure hair retention in most instances.

Teikoku Pharma USA has submitted a New Drug Application to the FDA for the product.